Take a look at the latest news from MWB.
Three forces – Brexit, Schrems II, and new SCC’s represent a critical moment for pharma clinical research and the transfer of personal data on EU residents.
Contact us to obtain a copy of our latest Briefing about why we think this is a “Perfect Storm” and what can be done about it.
December 4, 2020
For a brief, free-of-charge discussion about specific project-related problems or issues, feel free to email us at:
Associates: Pharma Data Protection
